Unbiased combination screening on repurposed drugs reveals synergistic potential of copanlisib and cerivastatin against chemoresistant high-grade serous ovarian cancer.
Saved in:
| Title: | Unbiased combination screening on repurposed drugs reveals synergistic potential of copanlisib and cerivastatin against chemoresistant high-grade serous ovarian cancer. |
|---|---|
| Authors: | Sun, Yu1 (AUTHOR), Wang, Yangyang1,2 (AUTHOR), Umbreen, Syed1,3 (AUTHOR), Pepperrell, Benjamin1 (AUTHOR), Buckley, Niamh1,3 (AUTHOR), Mullan, Paul3,4 (AUTHOR), Ali, Ahlam5 (AUTHOR), Furlong, Fiona1 (AUTHOR) f.furlong@qub.ac.uk |
| Source: | Journal of Ovarian Research. 11/6/2025, Vol. 18 Issue 1, p1-15. 15p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 17572215 |
|---|---|
| DOI: | 10.1186/s13048-025-01828-7 |
